Literature DB >> 2335755

Interleukin-4 downregulates interleukin-6 production in human peripheral blood mononuclear cells.

J D Lee1, S G Swisher, E H Minehart, W H McBride, J S Economou.   

Abstract

We report that recombinant human interleukin-4 (IL-4) downregulates interleukin-6 (IL-6) production by human peripheral blood mononuclear cells (PBMC). PBMC were preincubated for up to 24 hr in the presence of IL-4 (100 U/ml) and then activated with lipopolysaccharide B Escherichia coli 026:B6 (LPS, 10 micrograms/ml), recombinant human tumor necrosis factor-alpha (TNF-alpha, 200 U/ml), or Concanavalin A (Con A, 10 micrograms/ml). Although all these signals induced IL-6 production, IL-4-treated cells produced significantly reduced levels of IL-6 protein. This effect was dose and time dependent. We conclude that IL-4 is a potent downregulatory modulator of IL-6 expression in human PBMC.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2335755     DOI: 10.1002/jlb.47.5.475

Source DB:  PubMed          Journal:  J Leukoc Biol        ISSN: 0741-5400            Impact factor:   4.962


  15 in total

1.  In vivo cocaine administration influences lymphokine production and humoral immune response.

Authors:  P Di Francesco; S Marini; F Pica; C Favalli; E Tubaro; E Garaci
Journal:  Immunol Res       Date:  1992       Impact factor: 2.829

2.  Interleukin-4 induces the synthesis and secretion of MCP-1/JE by human endothelial cells.

Authors:  B J Rollins; J S Pober
Journal:  Am J Pathol       Date:  1991-06       Impact factor: 4.307

3.  IL-4R expression in AIDS-KS cells and response to rhIL-4 and IL-4 toxin (DAB389-IL-4).

Authors:  J Cai; T Zheng; J Murphy; C A Waters; G Y Lin; P S Gill
Journal:  Invest New Drugs       Date:  1997       Impact factor: 3.850

4.  IL-4 down-regulates IL-2-, IL-3-, and GM-CSF-induced cytokine gene expression in peripheral blood monocytes.

Authors:  F H Cluitmans; B H Esendam; J E Landegent; R Willemze; J H Falkenburg
Journal:  Ann Hematol       Date:  1994-06       Impact factor: 3.673

5.  Elevated monocyte interleukin-6 (IL-6) production in immunosppressed trauma patients. II. Downregulation by IL-4.

Authors:  G Szabo; K Kodys; C L Miller-Graziano
Journal:  J Clin Immunol       Date:  1991-11       Impact factor: 8.317

Review 6.  Cytokine-mediated gene therapy for cancer.

Authors:  A R Miller; W H McBride; K Hunt; J S Economou
Journal:  Ann Surg Oncol       Date:  1994-09       Impact factor: 5.344

7.  Immunological priming attenuates the in vivo pathophysiological response to lipopolysaccharide. Comparison of cytokine production, tissue injury, and lethality in complete Freund's adjuvant-primed mice and in unprimed mice.

Authors:  L E DeForge; E Takeuchi; D T Nguyen; D G Remick
Journal:  Am J Pathol       Date:  1994-03       Impact factor: 4.307

8.  Absence of exogenous interleukin-4-induced apoptosis of gingival macrophages may contribute to chronic inflammation in periodontal diseases.

Authors:  M Yamamoto; K Kawabata; K Fujihashi; J R McGhee; T E Van Dyke; T V Bamberg; T Hiroi; H Kiyono
Journal:  Am J Pathol       Date:  1996-01       Impact factor: 4.307

Review 9.  Interleukin-6 in clinical medicine.

Authors:  J Bauer; F Herrmann
Journal:  Ann Hematol       Date:  1991-06       Impact factor: 3.673

10.  Serum IL-4, IL-10 and IL-6 levels in inflammatory arthritis.

Authors:  F M Cicuttini; K A Byron; D Maher; A M Wootton; K D Muirden; J A Hamilton
Journal:  Rheumatol Int       Date:  1995       Impact factor: 2.631

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.